Barclays PLC Sorrento Therapeutics, Inc. Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.74 - $1.83 $249,430 - $616,834
337,068 Added 16.89%
2,332,719 $2.07 Million
Q3 2022

Nov 03, 2022
BUY
$1.51 - $2.88 $2.76 Million - $5.27 Million
1,829,031 Added 1097.73%
1,995,651 $3.13 Million
Q2 2022

Aug 12, 2022
BUY
$1.24 - $2.33 $143,543 - $269,723
115,761 Added 227.61%
166,620 $335,000
Q1 2022

May 16, 2022
SELL
$2.0 - $4.9 $655,140 - $1.61 Million
-327,570 Reduced 86.56%
50,859 $118,000
Q4 2021

Feb 14, 2022
BUY
$4.65 - $7.23 $1.13 Million - $1.75 Million
242,451 Added 178.3%
378,429 $1.76 Million
Q3 2021

Nov 09, 2021
BUY
$7.41 - $10.99 $694,139 - $1.03 Million
93,676 Added 221.45%
135,978 $1.04 Million
Q2 2021

Aug 13, 2021
SELL
$6.35 - $10.0 $1.06 Million - $1.68 Million
-167,596 Reduced 79.85%
42,302 $410,000
Q1 2021

May 13, 2021
SELL
$7.03 - $16.51 $852,078 - $2 Million
-121,206 Reduced 36.61%
209,898 $1.74 Million
Q4 2020

Feb 11, 2021
SELL
$5.76 - $11.95 $159,891 - $331,720
-27,759 Reduced 7.74%
331,104 $2.26 Million
Q3 2020

Nov 12, 2020
SELL
$6.17 - $18.82 $156,798 - $478,272
-25,413 Reduced 6.61%
358,863 $4 Million
Q2 2020

Aug 12, 2020
BUY
$1.73 - $6.76 $297,682 - $1.16 Million
172,071 Added 81.09%
384,276 $2.41 Million
Q1 2020

May 13, 2020
BUY
$1.57 - $4.76 $816 - $2,475
520 Added 0.25%
212,205 $391,000
Q4 2019

Feb 10, 2020
BUY
$1.45 - $4.17 $168,355 - $484,166
116,107 Added 121.48%
211,685 $716,000
Q3 2019

Nov 14, 2019
BUY
$2.05 - $2.69 $41,332 - $54,235
20,162 Added 26.73%
95,578 $205,000
Q2 2019

Aug 14, 2019
BUY
$2.67 - $4.38 $114,769 - $188,274
42,985 Added 132.54%
75,416 $201,000
Q1 2019

May 15, 2019
SELL
$1.86 - $5.94 $132,508 - $423,171
-71,241 Reduced 68.72%
32,431 $154,000
Q4 2018

Feb 14, 2019
BUY
$2.01 - $4.24 $44,535 - $93,945
22,157 Added 27.18%
103,672 $249,000
Q3 2018

Nov 14, 2018
BUY
$4.22 - $7.5 $187,519 - $333,270
44,436 Added 119.84%
81,515 $359,000
Q2 2018

Aug 14, 2018
SELL
$4.75 - $8.0 $324,999 - $547,368
-68,421 Reduced 64.85%
37,079 $267,000
Q1 2018

May 15, 2018
SELL
$4.5 - $9.95 $20,898 - $46,207
-4,644 Reduced 4.22%
105,500 $543,000
Q4 2017

Feb 14, 2018
BUY
$1.75 - $3.8 $139,027 - $301,887
79,444 Added 258.78%
110,144 $419,000
Q3 2017

Nov 14, 2017
BUY
$1.63 - $2.0 $50,041 - $61,400
30,700
30,700 $52,000

Others Institutions Holding SRNE

# of Institutions
13
Shares Held
5.53M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email